§ PHARMACEUTICALS
USD · PharmaceuticalsACRS
ACLARIS THERAPEUTICS INC
USDSector · Pharmaceuticals
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| BML Capital Management, LLC | 14.3M | 34.3% | ±0% |
| Deep Track Capital, LP | 9.3M | 0.6% | n/a |
| RA CAPITAL MANAGEMENT, L.P. | 6.8M | 0.3% | n/a |
| Vivo Capital, LLC | 6.7M | 0.7% | n/a |
| Vivo Capital, LLC | 6.7M | 0.7% | +125% |
| Vivo Capital, LLC | 6.7M | 0.7% | n/a |
◇ AC INTELLIGENCE
Top institutional owners for ACRS as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER84.6% · 85 holders
PASSIVE / INDEX8.7% · 9 holders
DEALER / BANK6.8% · 18 holders
TACTICAL / MACRO5.8% · 4 holders
QUALITY / COMPOUNDER1.3% · 11 holders
SYSTEMATIC / QUANT1.2% · 5 holders
ACTIVIST0.7% · 1 holder
INCOME / DEFENSIVE0.1% · 6 holders
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for ACRS in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention ACRS yet.